19 June 2013
Keywords: novartis, femara, gets, swiss, ok, new, use
Article | 16 August 2004
The Swiss Agency for Therapeutic Products has approved Novartis'Femara (letrozole) for the extended adjuvant treatment of postmenopausal
women with hormone ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 August 2004
18 June 2013
© 2013 thepharmaletter.com